Cargando…

New Perspectives on Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide; many recent advances have been made in many aspects of the disease. The aim of this article is to illustrate and discuss some of these advances in the management of different types of patients. Large-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celli, Bartolome R, Singh, Dave, Vogelmeier, Claus, Agusti, Alvar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464005/ https://www.ncbi.nlm.nih.gov/pubmed/36097591 http://dx.doi.org/10.2147/COPD.S365771

Ejemplares similares

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
por: Agustí, Alvar, et al.
Publicado: (2023)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
por: Singh, Dave, et al.
Publicado: (2016)

Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
por: Singh, Dave, et al.
Publicado: (2017)

Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
por: Celli, Bartolome R., et al.
Publicado: (2023)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

Informe de la Barcelona-Boston Lung Conference 2021
por: Celli, Bartolomé, et al.
Publicado: (2021)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Reply to Pouwels et al.: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Stockley, Robert A., et al.
Publicado: (2019)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

Characterization of T Lymphocytes in Chronic Obstructive Pulmonary Disease
por: Barnes, Peter J, et al.
Publicado: (2004)

Machine learning in chronic obstructive pulmonary disease
por: Zhang, Bochao, et al.
Publicado: (2023)

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
por: Glaab, Thomas, et al.
Publicado: (2010)

Skeletal Muscle Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Underlying Mechanisms and Physical Therapy Perspectives
por: Wang, Yingqi, et al.
Publicado: (2023)

Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2021)

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012)

Highlights and hot topics in the management of COPD: where are we heading?
por: Agustí, Alvar, et al.
Publicado: (2016)

Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease
por: Sauleda, Jaume, et al.
Publicado: (2008)

Roles of noncoding RNAs in chronic obstructive pulmonary disease
por: Qiao, Xin, et al.
Publicado: (2023)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
por: Faner, Rosa, et al.
Publicado: (2014)

From Laënnec’s Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome
Publicado: (2023)

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
por: Singh, Dave, et al.
Publicado: (2023)

Advanced Chronic Obstructive Pulmonary Disease: Innovative and Integrated Management Approaches
por: Zhou, Hai-Xia, et al.
Publicado: (2015)

Blood eosinophils in chronic obstructive pulmonary disease: A potential biomarker
por: Cui, Yanan, et al.
Publicado: (2023)

Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease
por: Fuster, Antonia, et al.
Publicado: (2008)

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives Dave Singh
por: Singh, Dave
Publicado: (2015)

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
por: de Torres, Juan P, et al.
Publicado: (2007)

A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease
por: Menche, Jörg, et al.
Publicado: (2014)

Markers of exacerbation severity in chronic obstructive pulmonary disease
por: Franciosi, Luigi G, et al.
Publicado: (2006)

Telerehabilitation for Chronic Obstructive Pulmonary Disease Patients: An Underrecognized Management in Tertiary Care
por: Bairapareddy, Kalyana Chakravarthy, et al.
Publicado: (2018)

Animal models: An essential tool to dissect the heterogeneity of chronic obstructive pulmonary disease
por: Jiang, Jingxian, et al.
Publicado: (2023)

Amerindian Ancestry Influences Genetic Susceptibility to Chronic Obstructive Pulmonary Disease
por: Díaz-Peña, Roberto, et al.
Publicado: (2020)

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vk5n46r7ksvdu027c2av8ski6n